ContraFect Corp
...focused on discovering & developing differentiated biologic therapies for life-threatening, drug-resistant infections
10 employees · est. 2008 · Yonkers, United States
ContraFect Corp is the older company (2009 vs 2008); ANTABIO is the larger of the two.
Side-by-Side Comparison
| Metric | ANTABIO | ContraFect Corp |
|---|---|---|
| Founded | ||
| Founded | 2009 | 2008 older |
| Headquarters | ||
| Headquarters | France | Yonkers, United States |
| Employees | ||
| Employees | 25 larger | 10 |
| Industry | ||
| Industry | Biotechnology, Life Sciences, Medical Devices | Biotechnology, Health Care |
| Funding Stage | ||
| Funding Stage | Series B | Post Ipo Equity |
| Total Funding | ||
| Total Funding | $52.23M | $249.07M |
| Funding Rounds | ||
| Funding Rounds | 16 | 14 |
| Services | ||
| Services | Not tracked yet | Not tracked yet |
| Target Customers | ||
| Target Customers | Not tracked yet | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Biopharmaceutical, Antibacterial Treatments, Drug-resistant Infections, Metalloenzymes Inhibitors, Bacterial Metallo ß-lactamases, Carbapenem Combination, Drug Discovery, Drug Development, Antibiotic Adjuvant, Nosocomial Infections, Clinical-stage, Wellcome Trust Seeding Drug Discovery Award, Labege, France | Biologic Therapies, Drug-resistant Infections, Direct Lytic Agents, Lysins, Amurin Peptides, Antimicrobial-resistant Infections, Antibiotic-resistant Infections, Phase 2 Clinical Trial, Phase 3 Clinical Study, Breakthrough Therapy Designation, Monoclonal Antibodies, Multi-drug Resistant Infections, Biotechnology Company, Yonkers, New York |
| Website | ||
| Website | antabio.com | contrafect.com |
About ANTABIO
Antabio is a privately-held clinical-stage biopharmaceutical company founded in 2009, with a focus on developing novel and highly differentiated antibacterial treatments for drug-resistant infections. The company operates in the biotechnology, life sciences, and medical devices industries and is bas...
About ContraFect Corp
ContraFect Corp is a biotechnology company focused on discovering and developing differentiated biologic therapies for life-threatening, drug-resistant infections. The company is addressing the pressing issue of antimicrobial-resistant infections, which account for an estimated 700,000 deaths worldw...
We will tell you when either one moves
BounceWatch watches ANTABIO and ContraFect Corp for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at ANTABIO and ContraFect Corp — by email.
Frequently Asked Questions
Compare ANTABIO with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at ANTABIO on 11 Sep 2024, and ContraFect Corp on 11 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.